Management of Autoimmune ILD

Elizabeth R. Volkmann

The ABCs in Immune Mediated Myopathies

ZINCARE

E. Tiniakou

Clinical and Translational Studies in In-Vitro and an In-Vivo Mouse …

Lan Weiss

Weakness: Common Neuromuscular Complaint

ZINCARE

U. Thirugnanam

Pulmonary Complications of Rheumatic Diseases

National Jewish Health

J. Solomon

Co-Management of CTD-ILD: A Rheumatology and Pulmonology Perspective

West Virginia State Rheumatology Society

R. Aggarwal, D. Sullivan

Myelitis vs. Myelopathies: A Primer for Residents

ZINCARE

C. A. Pardo

Rheumatology Lung Disease Panel

Michigan Medicine

K. M Chan, D. Roofeh, B. Wang

ATS 2024 Insights: Management Decisions After Early Detection of CTD…

Insights from 2024 ATS Annual Meeting

S. Matson

Inflammatory Myopathies - Update on Therapies

EULAR® 2024 Insights

B. Maurer

Polymyositis vs. Inclusion Body Myositis, Rare Entities: Differentia…

University of Miami

O. Carbunar

SAPHO

Cleveland Clinic Rheumatology

A. Brown

New and Emerging Treatments in Fibrosing Skin Disorders

Cleveland Clinic Rheumatology

S. Chatterjee

Combining Systemic Therapies in Connective Tissue Diseases

Carole Bitar

What is MCTD? The Great Debate With Dr. Christopher-Stine

RheumNow

L. Christopher-Stine